Stelliam Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Stelliam Investment Management's AMGN Position: Q4 2018 in Review
Stelliam Investment Management sold out of Amgen (AMGN) in Q4 2018, closing a stake of 130,500 shares — an estimated $27.1M sold.
Stelliam Investment Management first reported a position in AMGN in Q4 2013 and held it in 20 quarters. The position peaked at $93.5M in Q1 2016. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.
- Stelliam Investment Management reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
- Stelliam Investment Management sold 130,500 Amgen shares in Q4 2018, an estimated $27.1M.
- Stelliam Investment Management first reported a position in Amgen in Q4 2013 and held it in 20 quarters.
- Stelliam Investment Management's Amgen position peaked at $93.5M in Q1 2016.
- 1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.
Based on Stelliam Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.